(→Research) |
|||
Line 3: | Line 3: | ||
=Human Practice= | =Human Practice= | ||
− | Our team organize and participate to many events in order to promote the synthetic biology and our project. Here is listed all the events and the team member who participate to them. | + | Our team organize and participate to many events in order to promote the synthetic biology and our project. Here is listed all the events and the team member who participate to them. We also meet stakeholders in order to learn more about CRISPR-Cas9. |
− | Lecture CRIPR Cas-9: We made a conference in our University about the societal issues of CRISPR-Cas9. Claire, Marin and Laetitia contacted the lecturers. Caroline introduced the CRISPR-Cas9 technology and its origins. Laetitia introduced the the iGEM competition and the Paris Saclay's team. | + | Mrs Geneviève Fioraso : French deputy, former ministry of Higer Education and research. She wrote a report on synthetic biology for the French Parliament. |
+ | Mrs Catherine Procaccia : French Senator. She is working on a report for the French Parliament on economical and environnemental issues of new biotechnologies, especially CRISPR-Cas9. | ||
+ | Mrs Agnès Ricroch : professor at AgroParisTech school working on plants and their regulations. | ||
+ | Mr Olivier Fellous : Marc Fellous, Emeritus Professor at Paris Diderot University and Medical Doctor | ||
+ | Mr Eric Enderlin : French and European Patent Attorney at Novagraaf | ||
+ | |||
+ | Lecture CRIPR Cas-9: We made a conference in our University about the societal issues of CRISPR-Cas9. Claire, Marin and Laetitia contacted the lecturers. Caroline introduced the CRISPR-Cas9 technology and its origins. Laetitia introduced the the iGEM competition and the Paris Saclay's team. The lecturers were Pierre Walrafen, an European Patent Attorney, and Jean-Pierre Faure, Jean Denis Faure, a researcher and professor at AgroParisTech school. | ||
Exposition in Nanterre University: | Exposition in Nanterre University: | ||
Line 31: | Line 37: | ||
Mr. David BIKARD, a reseacher at the Institut Pasteur in Paris and an expert on CRISPR-Cas9 utilization, was meet by Victor, Caroline and Léa. He helped us choosing which orthologous dCas9s to use for our project, in order to maintain the sgRNA/dCas9 recognition specificity. | Mr. David BIKARD, a reseacher at the Institut Pasteur in Paris and an expert on CRISPR-Cas9 utilization, was meet by Victor, Caroline and Léa. He helped us choosing which orthologous dCas9s to use for our project, in order to maintain the sgRNA/dCas9 recognition specificity. | ||
− | Mr. | + | Mr.Espéli who is an expert in CRISPR-Cas9. AUTRE CHERCHEURS... |
Revision as of 12:00, 7 October 2016